Target intelligence / Profile preview

Skin microecology (null)

Target
null
Molecular classification
Other (a biological ecosystem, not a molecule, protein, or gene family)
01

Overview

Skin microecology describes the dynamic and complex ecosystem on the skin surface, which is colonized by a wide variety of microorganisms (bacteria, fungi, viruses, mites) that interact with the host's immune system and environmental factors to maintain skin health. The skin's microbiome plays crucial roles in protecting against pathogens, educating immune responses, modulating inflammation, and facilitating wound healing. Disruptions to this ecological balance (such as from disease, medications, or environmental changes) can contribute to skin disorders or increase susceptibility to infection. Efforts to modulate the skin microecology therapeutically (probiotics, bacteriotherapy, targeted antimicrobials, personalized skincare) are ongoing, though significant scientific and safety challenges remain. This entry does not correspond to a discrete molecular target and cannot be used directly for structured drug target data without clarification or more specificity.

Other names
Skin microbiomeskin microfloraskin microbiota
02

Mechanism of action

Modulation of microbiome composition to restore balance; Targeting pathogenic microbes (antimicrobial activity); Enhancing beneficial microbial activities (via probiotics, prebiotics); Immunomodulation (some therapeutics may engage host immune pathways through microbiota changes)

03

Biological functions

Physical barrier maintenanceImmune system education and modulationProtection against infection/pathogensControl of inflammation and wound healingMetabolism of skin substances (e.g., sebum, fatty acids)
04

Disease associations

Infection (disruptions can lead to susceptibility)Inflammation and inflammatory skin diseases (e.g., atopic dermatitis, psoriasis)Other skin disorders (acne, radiation dermatitis, eczema)Potential role in cancer and skin aging
05

Safety considerations

Risk of introducing pathogenic microbes in bacteriotherapyAntimicrobial resistanceImbalance leading to opportunistic infections or inflammation ("dysbiosis")Limited understanding of long-term effects of manipulating skin microbiota
06

Interacting drugs

Bacteriotherapeutics (live bacterial strains)

3 more in the full profile.

07

Biomarkers

Specific bacterial genera or species abundance (e.g., Staphylococcus epidermidis, Cutibacterium acnes, Staphylococcus aureus) for disease risk and stratificationMicrobial diversity metricsPresence or abundance of antimicrobial resistance genes

Beyond the preview

Go deeper on Skin microecology (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin microecology (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call